Literature DB >> 11821176

In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.

Susan L Pendland1, Chad R Messick, Rose Jung.   

Abstract

The synergistic potential of levofloxacin, ofloxacin and ciprofloxacin combined with aztreonam, ceftazidime, or piperacillin was compared using 24 strains of Pseudomonas aeruginosa with varying susceptibility profiles. Levofloxacin and ciprofloxacin demonstrated similar in vitro activity, with ofloxacin demonstrating less activity compared to the other agents. Predominantly additive effects were seen with all combinations, with no significant differences detected between the fluoroquinolone agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821176     DOI: 10.1016/s0732-8893(01)00312-1

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  2 in total

1.  Microparticles for inhalational delivery of antipseudomonal antibiotics.

Authors:  Michael D Tsifansky; Yoon Yeo; Oleg V Evgenov; Evangelia Bellas; John Benjamin; Daniel S Kohane
Journal:  AAPS J       Date:  2008-05-03       Impact factor: 4.009

2.  In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa.

Authors:  Vladimir Chachanidze; Aixa Curbelo-Irizarry; Deborah Ashcraft; George Pankey
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.